The Osteoporosis Treatment Market Growth is Accelerated by Rising Awareness of Disease Treatment

Osteoporosis, commonly known as brittle bone disease, is characterized by low bone mass and structural deterioration of bone tissue. It leads to bone fragility and elevated risk of fractures, especially vertebral compression fractures and hip fractures. Osteoporotic fractures are a major cause of morbidity and mortality. Various medications are available in the market for the treatment and management of osteoporosis which help in improving bone mineral density and reducing the risk of fractures. These include bisphosphonates, selective estrogen receptor modulators, parathyroid hormone analogs, RANK ligand inhibitors, sodium-based phosphate tablets, and calcium and vitamin D supplements.

The global Osteoporosis Treatment Market is estimated to be valued at US$ 14.01 billion in 2023 and is expected to exhibit a CAGR of 3.8% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.

Market key trends:
One of the key trends driving the osteoporosis treatment market growth is the rising awareness among people about the disease, its associated health risks, and availability of various treatment options. Various government and non-profit organizations are regularly conducting educational programs and campaigns to educate people about osteoporosis. They emphasize on the importance of early diagnosis and treatment to prevent fractures. This has increased the diagnosis rates and uptake of drugs for osteoporosis management. With growing geriatric population worldwide, the prevalence of osteoporosis is also increasing rapidly which is anticipated to fuel the demand for osteoporosis drugs during the forecast period.

Segment Analysis
The global osteoporosis treatment market is segmented on the basis of drug type, route of administration, distribution channel, and end user. Based on drug type, the bisphosphonates segment currently dominates the market due to its high efficacy, ease of use, and availability of generic drugs. Among bisphosphonates, alendronate sodium, risedronate sodium, ibandronate sodium and zoledronic acid hold major market share owing to their long term effectiveness and affordable price.

Key Takeaways
The global osteoporosis treatment market is expected to witness high growth. The market was valued at US$ 14.01 billion in 2023 and is projected to reach US$ 17.55 billion by 2030, expanding at a CAGR of 3.8% during the forecast period.

Regional analysis: North America currently dominates the global market in terms of revenue. This is attributed to rising health awareness among people, development of advanced drugs and techniques, and presence of key players in the region. Asia Pacific is expected to be the fastest growing market during the forecast period owing to surge in geriatric population, rise in purchasing power, improving healthcare infrastructure and increasing focus of key players on emerging economies in the region.

Key players operating in the osteoporosis treatment market are Teva Pharmaceutical Industries Ltd., DAIICHI SANKYO COMPANY, LIMITED, Amgen Inc., Dr. Reddy’s Laboratories Ltd., Viatris Inc., Ligand Pharmaceuticals Incorporated, Eli Lilly and Company, Asahi Kasei Corporation, F. Hoffmann-La Roche Ltd, EffRx Pharmaceuticals SA, Novartis AG, Merck & Co., Inc., GSK plc., and Pfizer Inc. Teva Pharmaceuticals, Amgen and Daiichi dominate the global bisphosphonates segment.

Comments

Post a Comment

Popular posts from this blog

Neuroendocrine Cancer is the fastest growing segment fueling the growth of Pituitary Cancer Market

Image
The pituitary cancer market comprises of medical treatment options for patients diagnosed with pituitary cancer. Pituitary cancers are rare tumors that start in the pituitary gland which is a pea-sized gland located at the base of the brain.  The global Pituitary Cancer Market is estimated to be valued at US$ 380.7 Mn in 2023 and is expected to exhibit a CAGR of 9.6% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.    Market key trends: One of the key trends fueling the growth of the pituitary cancer market is rising preference of targeted drug therapy over conventional chemotherapy. Targeted drug therapies mainly include somatostatin analogs and dopamine agonists which directly act on cancer cells and have less side effects compared to chemotherapy. These targeted drugs are effective in controlling symptoms and slowing tumor growth in patients with hormone secreting pituitary adenomas and carcinomas. The targe...
Read more

Enhancing Patient Care and Comfort: The Evolution of Hospital Beds

Image
  Hospital beds play a crucial role in patient care, providing comfort, safety, and functionality for individuals requiring medical attention. Over the years, advancements in technology and design have revolutionized hospital beds, leading to improved patient outcomes and caregiver efficiency. From basic adjustable beds to sophisticated models equipped with cutting-edge features, the evolution of hospital beds has transformed the healthcare landscape. Evolution of Hospital Beds: Historically, hospital beds were simple in design, primarily consisting of a metal frame with adjustable height and manual controls. However, as medical practices advanced and patient needs became more complex, the demand for more versatile and ergonomic hospital beds grew. In recent decades, significant strides have been made in the development of hospital bed technology. Modern hospital beds are designed with a focus on patient comfort, safety, and mobility. Features such as electronic controls, motorize...
Read more

Dry Eye Disease Market is Estimated to Witness High Growth Owing to Rising Awareness About Disease Management

Image
  Dry eye disease, also known as keratoconjunctivitis sicca, is a multifactorial disease of the ocular surface characterized by lack of sufficient moisture and tear film instability. Common symptoms of dry eye include stingy or burning sensation in eyes and blurred vision.   Market Dynamics : The Dry Eye Disease Market is witnessing high growth owing to rising awareness about disease management and increasing number of people experiencing symptoms of dry eyes. According to the report, increasing usage of electronic devices and prolonged screen time is a major driver fueling the demand for dry eye treatments. Additionally, growing geriatric population worldwide who are more prone to dry eyes is also contributing to the market growth. Availability of various treatment options along with new product launches is further expected to boost the market during forecast period.   Increasing Prevalence of Dry Eye Disease is Driving Market Growth   One of the major market drive...
Read more